Class 2 Drug Alert (Action Within 48 Hours): Typharm Limited - GoldenEye 0.15% w/w eye ointment - Dibrompropamidine Isetionate - EL (13)A/06


The following section/document has been added/updated Title: Class 2 Drug Alert (Action Within 48 Hours): Typharm Limited - GoldenEye 0.15% w/w eye ointment - Dibrompropamidine Isetionate - EL (13)A/06 Summary Cambridge Healthcare Supplies Limited, distributors of GoldenEye 0.15% w/w eye ointment on behalf of Marketing Authorisation Holder, Typharm Limited are recalling all remaining stock of one batch to Pharmacy, clinic and wholesaler level, due to an issue with seal integrity and compromised sterility assurance, introduced during the filling process.
Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your subscriber preferences page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com. All other enquiries can be directed to email.support@mhra.gsi.gov.uk. This is an automatically generated email. Please do not reply directly to this notification. This service is provided to you at no charge by the MHRA. Medicines and Healthcare products Regulatory Agency 151 Buckingham Palace Road, Victoria, London, SW1W 9SZ

The following section/document has been added/updated

Title:

Class 2 Drug Alert (Action Within 48 Hours): Typharm Limited - GoldenEye 0.15% w/w eye ointment - Dibrompropamidine Isetionate - EL (13)A/06

Summary

Cambridge Healthcare Supplies Limited, distributors of GoldenEye 0.15% w/w eye ointment on behalf of Marketing Authorisation Holder, Typharm Limited are recalling all remaining stock of one batch to Pharmacy, clinic and wholesaler level, due to an issue with seal integrity and compromised sterility assurance, introduced during the filling process.

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your subscriber preferences page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com. All other enquiries can be directed to email.support@mhra.gsi.gov.uk.

This is an automatically generated email. Please do not reply directly to this notification. This service is provided to you at no charge by the MHRA.

Medicines and Healthcare products Regulatory Agency
151 Buckingham Palace Road, Victoria, London, SW1W 9SZ

This email has been sent to Email Address because you are subscribed to the MHRA Drug Alerts email channel.